Aveanna Healthcare Reports Strong Q2 2025 Financial Growth

The latest announcement is out from Aveanna Healthcare Holdings ( (AVAH) ).

Aveanna Healthcare Holdings announced its second-quarter financial results for 2025, showing significant growth in revenue and adjusted EBITDA compared to the previous year. The company reported a 16.8% increase in revenue to $589.6 million and a 93.6% increase in adjusted EBITDA to $88.4 million. The acquisition of Thrive Skilled Pediatric Care has expanded Aveanna’s pediatric services, contributing to its strategic transformation and market expansion. The company has raised its full-year 2025 revenue guidance to over $2.3 billion and adjusted EBITDA to over $270 million, reflecting strong operational performance and growth momentum.

The most recent analyst rating on (AVAH) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Aveanna Healthcare Holdings stock, see the AVAH Stock Forecast page.

Spark’s Take on AVAH Stock

According to Spark, TipRanks’ AI Analyst, AVAH is a Neutral.

Aveanna Healthcare’s overall stock score reflects significant financial instability due to high leverage and negative equity. While earnings call insights and corporate events suggest positive strategic developments, technical analysis and valuation metrics indicate substantial risks and overvaluation concerns.

To see Spark’s full report on AVAH stock, click here.

More about Aveanna Healthcare Holdings

Aveanna Healthcare Holdings Inc. is a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations. The company is committed to delivering cost-effective and high-quality home care services, with a national footprint that emphasizes value for payor and government partners.

Average Trading Volume: 540,127

Technical Sentiment Signal: Sell

Current Market Cap: $737.5M

See more data about AVAH stock on TipRanks’ Stock Analysis page.